From November 11, 2022 to November 30, 2022, the company has repurchased 0 shares, representing 0% for CAD 0 million. With this, the company has completed the repurchase of 0 shares, representing 0% for CAD 0 million under the buyback announced on November 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.67 CAD | -1.47% |
|
-4.29% | -19.28% |
1st Jan change | Capi. | |
---|---|---|
-19.28% | 44.25M | |
+4.94% | 212M | |
-15.46% | 175M | |
+26.16% | 165M | |
-28.57% | 121M | |
+300.00% | 121M | |
+21.20% | 110M | |
+92.70% | 105M | |
-60.09% | 84.3M | |
-15.38% | 73.86M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.